diabetes
Fixed-dose       combination therapy with a calcium channel blocker and an angiotensin-converting        enzyme (ACE) inhibitor can potentially reduce pharmacy costs if given to patients       who are taking both drugs independently and to patients who are taking a calcium        channel blocker but should probably also be taking an ACE inhibitor (e.g.,       patients with diabetes or congestive heart failure).
Fixed-dose       combination therapy with a calcium channel blocker and an angiotensin-converting        enzyme (ACE) inhibitor can potentially reduce pharmacy costs if given to patients       who are taking both drugs independently and to patients who are taking a calcium        channel blocker but should probably also be taking an ACE inhibitor (e.g.,        @OBJECT$   @PREDICAT$   @SUBJECT$  or congestive heart failure).